Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 26% ± 8% | |
lung | 8 studies | 33% ± 13% | |
intestine | 6 studies | 26% ± 14% | |
kidney | 5 studies | 28% ± 6% | |
lymph node | 5 studies | 21% ± 3% | |
pancreas | 4 studies | 26% ± 9% | |
bone marrow | 4 studies | 19% ± 2% | |
eye | 4 studies | 28% ± 12% | |
adrenal gland | 3 studies | 20% ± 3% | |
liver | 3 studies | 31% ± 17% | |
thymus | 3 studies | 47% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2015.04 | 1445 / 1445 | 100% | 75.21 | 183 / 183 |
ovary | 100% | 2065.82 | 180 / 180 | 100% | 109.40 | 430 / 430 |
skin | 100% | 2535.04 | 1809 / 1809 | 100% | 106.72 | 472 / 472 |
uterus | 100% | 2237.53 | 170 / 170 | 100% | 122.02 | 459 / 459 |
brain | 100% | 2116.53 | 2641 / 2642 | 100% | 161.58 | 705 / 705 |
thymus | 100% | 2120.10 | 653 / 653 | 100% | 92.66 | 604 / 605 |
prostate | 100% | 2379.74 | 245 / 245 | 100% | 100.43 | 501 / 502 |
liver | 100% | 1129.98 | 226 / 226 | 100% | 61.63 | 405 / 406 |
lung | 100% | 2251.56 | 578 / 578 | 100% | 100.85 | 1152 / 1155 |
kidney | 100% | 2278.81 | 89 / 89 | 100% | 72.82 | 898 / 901 |
breast | 100% | 2552.85 | 459 / 459 | 99% | 120.23 | 1112 / 1118 |
intestine | 100% | 2133.29 | 966 / 966 | 99% | 92.01 | 524 / 527 |
pancreas | 100% | 1027.02 | 327 / 328 | 99% | 81.14 | 177 / 178 |
stomach | 100% | 1672.46 | 359 / 359 | 99% | 85.93 | 283 / 286 |
bladder | 100% | 2193.52 | 21 / 21 | 99% | 119.99 | 498 / 504 |
adrenal gland | 100% | 2638.05 | 258 / 258 | 97% | 63.54 | 224 / 230 |
adipose | 100% | 2433.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2277.77 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 74.33 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 182.08 | 29 / 29 |
spleen | 100% | 3147.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 106.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 89.07 | 1 / 1 |
peripheral blood | 99% | 2473.57 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1295.66 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1094.05 | 793 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0045948 | Biological process | positive regulation of translational initiation |
GO_0000956 | Biological process | nuclear-transcribed mRNA catabolic process |
GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_0000932 | Cellular component | P-body |
GO_0005665 | Cellular component | RNA polymerase II, core complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031369 | Molecular function | translation initiation factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0003727 | Molecular function | single-stranded RNA binding |
Gene name | POLR2G |
Protein name | DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G) (RNA polymerase II 19 kDa subunit) (RPB19) RNA polymerase II subunit G |
Synonyms | RPB7 |
Description | FUNCTION: Core component of RNA polymerase II (Pol II), a DNA-dependent RNA polymerase which synthesizes mRNA precursors and many functional non-coding RNAs using the four ribonucleoside triphosphates as substrates. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. POLR2G/RPB7 is part of a subcomplex with POLR2D/RPB4 that binds to a pocket formed by POLR2A/RPB1, POLR2B/RPB2 and POLR2F/RPABC2 at the base of the clamp element. The POLR2D/RPB4-POLR2G/RPB7 subcomplex seems to lock the clamp via POLR2G/RPB7 in the closed conformation thus preventing double-stranded DNA to enter the active site cleft. The POLR2D/RPB4-POLR2G/RPB7 subcomplex binds single-stranded DNA and RNA. . |
Accessions | H0YEE4 ENST00000531944.5 ENST00000301788.12 ENST00000524819.5 ENST00000533442.5 E9PIU7 ENST00000525455.5 E9PS03 P62487 E9PKH3 ENST00000531996.5 |